UNSPSC 51343109: Ibacitabine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H12IN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3EK8532DZV, chemically known as cytidine, 2-deoxy-5-iodo- (8ci)(9ci) but generally known as ibacitabine, which bears US NIH Compound Identifier 65050. European Medicines Agency schedules Ibacitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08090MIG. The term IBACITABINE is an International Non-Proprietary Name.

UNSPSC 51343109 Ibacitabine, a Commodity code, shows minimal alignment between its nominal classification and recent state and local procurement activity. The code nominally describes a specific antiviral pharmaceutical, yet the recent solicitations tagged under it span naloxone and drug deactivation systems, direct-to-manufacturer pharmacy benefit programs, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and over-the-counter products—a collection that reflects procurement tagging inconsistencies rather than coherent commodity scope. State and local issuing bodies treating this code appear to include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire and rescue divisions (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local jurisdictions across multiple states including Oregon). The actual work being bought comprises pharmaceutical distribution logistics, emergency medical consumables for first-response units, pharmacy benefit program structuring and direct contracting with manufacturers, and bulk supply agreements for generic medications and OTC products.

Recent activity spans Florida, Texas, and a multistate cooperative covering Minnesota and Oregon. Seminole County, Florida posted an IFB (IFB60459723LAS) due July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building. The City of Tampa issued an ITB (26P00145) due March 13, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division at an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026, seeking vendor capabilities for implementing a direct-to-manufacturer prescriptions program outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) due March 26, 2026, to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract effectiveness July 1, 2026. The code does not show sufficient recent activity with clear relevance to ibacitabine specifically to support targeted business development under its nominal scope.